Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Needle free injection technology (NFIT) encompasses a wide range of drug delivery systems that drive drugs through the skin using any of the forces as Lorentz, shock waves, pressure by gas or electrophoresis which propels the drug through the skin, virtually nullifying the use of hypodermic needle.The devices as such are available in reusable forms. In contrast to the traditional syringes, NFIT not only gives the user freedom from unnecessary pain but drugs in the form of solid pallets can also be administered. The future of this technology is promising ensuring virtually painless and highly efficient drug delivery. The major drawback associated with this technology is postadministration “wetness” of the skin which may, if not taken care of, harbor dust and other untoward impurities.This technology is being backed by organizations as World Health Organization, Centers for Disease Control and Prevention and various groups including Bill and Melinda Gates Foundation. This technology is not only touted to be beneficial for the pharma industry but developing world too find it highly useful in mass immunization programs, bypassing the chances of needle stick injuries and avoiding other complications including those arising due to multiple uses of single needle.Better patient compliance has been observed.
The Needle-Free Injection Device market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.
Considering the influence of COVID-19 on the global Needle-Free Injection Device market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Needle-Free Injection Device Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Needle-Free Injection Device market are:
Crossject Medical Technology
Injex Pharma
Antares Pharma
PharmaJet
Glide Pharma
Eternity Healthcare
National Medical Products
Inovio
Akra Dermojet
Medical International Technologies
Penjet
Zogenix
Activa Brand Products
Valeritas
Most important types of Needle-Free Injection Device products covered in this report are:
Powder Injections
Liquid Injections
Depot or Projectile Injection
Most widely used downstream fields of Needle-Free Injection Device market covered in this report are:
Drug Injection
Cosmetic Surgery Use
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
2020
The Needle-Free Injection Device market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.
Considering the influence of COVID-19 on the global Needle-Free Injection Device market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Needle-Free Injection Device Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Needle-Free Injection Device market are:
Crossject Medical Technology
Injex Pharma
Antares Pharma
PharmaJet
Glide Pharma
Eternity Healthcare
National Medical Products
Inovio
Akra Dermojet
Medical International Technologies
Penjet
Zogenix
Activa Brand Products
Valeritas
Most important types of Needle-Free Injection Device products covered in this report are:
Powder Injections
Liquid Injections
Depot or Projectile Injection
Most widely used downstream fields of Needle-Free Injection Device market covered in this report are:
Drug Injection
Cosmetic Surgery Use
Major Region
s or countries covered in this report:North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
Years considered for this report:
Historical Years:
2016-2020Base Year:
2020Estimated Year:
2021Forecast Period:
2021-2026Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
